Eli Lilly Just Made Another Move to Dominate the Weight Loss Market: Should You Buy the Stock?
15/6 13:30
Eli Lilly (NYSE: LLY) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following recent clinical wins, the company may even be taking the lead ahead of its only real competitor in the field, Novo Nordisk....